Humana Inc. (NYSE:HUM) Given Consensus Rating of “Hold” by Brokerages

Shares of Humana Inc. (NYSE:HUM) have received a consensus recommendation of “Hold” from the twenty-five ratings firms that are currently covering the stock, Marketbeat reports. Nineteen equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $304.15.

Several equities research analysts have commented on the stock. TD Cowen boosted their price target on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Deutsche Bank Aktiengesellschaft reduced their price target on Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. UBS Group dropped their price objective on Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, October 4th. Jefferies Financial Group downgraded Humana from a “buy” rating to a “hold” rating and cut their price objective for the company from $519.00 to $253.00 in a report on Monday, October 7th. Finally, Oppenheimer lowered their target price on shares of Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a report on Thursday, October 3rd.

Humana Stock Up 0.5 %

HUM stock opened at $274.12 on Wednesday. The business has a 50-day moving average of $274.13 and a 200-day moving average of $324.38. Humana has a fifty-two week low of $213.31 and a fifty-two week high of $486.00. The stock has a market capitalization of $33.01 billion, a P/E ratio of 24.28, a P/E/G ratio of 2.15 and a beta of 0.53. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The firm had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. On average, sell-side analysts anticipate that Humana will post 16.14 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.29%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is currently 31.36%.

Hedge Funds Weigh In On Humana

Several hedge funds have recently bought and sold shares of the company. Sequoia Financial Advisors LLC increased its stake in shares of Humana by 44.0% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 2,334 shares of the insurance provider’s stock valued at $872,000 after purchasing an additional 713 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Humana by 9.9% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 8,713 shares of the insurance provider’s stock worth $3,256,000 after acquiring an additional 787 shares during the last quarter. Envestnet Portfolio Solutions Inc. lifted its holdings in shares of Humana by 14.4% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 5,490 shares of the insurance provider’s stock worth $2,051,000 after acquiring an additional 689 shares during the last quarter. AdvisorNet Financial Inc boosted its stake in shares of Humana by 18.6% in the 2nd quarter. AdvisorNet Financial Inc now owns 287 shares of the insurance provider’s stock valued at $107,000 after purchasing an additional 45 shares in the last quarter. Finally, 180 Wealth Advisors LLC grew its holdings in shares of Humana by 13.0% during the 2nd quarter. 180 Wealth Advisors LLC now owns 1,156 shares of the insurance provider’s stock valued at $439,000 after purchasing an additional 133 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.